HOME | CONTACT US | LOGIN | REGISTER
 
INVESTOR RELATIONS
Investor Home
Stock Quote/Chart
Stock Price Lookup
Calculator
Events & Presentations
Annual Meeting
News Releases
SEC Filings
Information Request
Email Alerts
 
  Investor Tool Kit
  PDF Corporate Fact Sheet
  PDF Investor Presentation
  HTML file Annual Report & Proxy
 
 
NASDAQ: GNBT 0.62 - 0.01
10 Mar 2010 1:38 PM ET
 
Print Print   Email Email page
 
 
Press Releases
 
Generex Establishes Key Strategic Relationships for the Development of a Distribution Network for Generex Oral-lyn(R) Under the FDA's Expanded Access Treatment IND Program
  4 Mar 2010
   
Generex Subsidiary Antigen Express Receives Patent in China for Its Ii-Key Peptide Vaccine Technology
  2 Mar 2010
   
Generex Announces Participation in 2010 Arab Health Congress
  25 Jan 2010
   
Generex Biotechnology Highlights OTC Product Line at The Vitamin, Diet & Sports Nutrition Efficient Program Planning Session
  20 Jan 2010
   
Generex Makes Podium Presentation of Vaccine Technology Platform With Cancer & Influenza Updates at PepTalk 2010
  19 Jan 2010
   
Generex Biotechnology Corporation: Introducing Revolutionary Cancer Immunotherapy While Redefining the Treatment for T1D, T2D
  14 Jan 2010
   
Generex Biotechnology Corporation to Present at the OneMedForum 2010 Conference
  13 Jan 2010
   
Generex Receives Over $800,000 in Initial Purchase Orders for Crave-NX(TM) 7-Day Diet Aid Spray
  13 Jan 2010
   
Major U.S. Pharmacy Chain to Market Generex's Crave-NX(TM) 7-Day Diet Aid Spray Throughout Its Nationwide Network of Over 7,000 Stores
  11 Jan 2010
   
Generex: a Year in Review; Setting the Stage for a Year of Progress (Part Three)
  8 Jan 2010
   
Generex: a Year in Review; Setting the Stage for a Year of Progress (Part Two)
  7 Jan 2010
   
Generex: a Year in Review; Setting the Stage for a Year of Progress
  6 Jan 2010
   
Generex MENA Supplies Products to New International Territories
  17 Dec 2009
   
Generex Clarifies Previous Announcement of Breast Cancer Study Interim Results
  15 Dec 2009
   
Generex Presents Encouraging Interim Results of Phase II Breast Cancer Study
  14 Dec 2009
   
Generex Inks Deal With Sanofi-Aventis for Insulin Supply
  9 Dec 2009
   
Study Finds Generex Oral-lyn(TM) is Safe, Effective, May Reduce Complications of Insulin-Dependent Diabetes
  3 Dec 2009
   
New York City Drug Store Chain Duane Reade Holdings, Inc. to Carry Crave-NX(TM) 7-Day Diet Aid Spray
  1 Dec 2009
   
Generex Scientist Makes Presentation at National Influenza Congress
  23 Nov 2009
   
Generex Receives Confirmation of Extension of Compliance Period From NASDAQ
  10 Nov 2009
   
Generex's Glucose RapidSpray(TM) Featured on Doggie Chronicles Radio
  2 Nov 2009
   
Generex Announces That It Will Not Exercise Its Rights to Issue and Sell Stock Under Its At Market Issuance Sales Agreement With WM Smith Until Further Notice
  29 Oct 2009
   
Generex Biotechnology Receives Purchase Order for Generex Oral-lyn(TM) for Algerian Market
  21 Oct 2009
   
Generex: Going Concern Qualification
  20 Oct 2009
   
Generex to Present Clincial Data at the 20th World Diabetes Congress of the International Diabetes Federation
  20 Oct 2009
   
Generex Launches Generex Oral-lyn(TM) in Algeria
  16 Oct 2009
   
Generex Announces USFDA Price Approval for Generex Oral-lyn(TM) in the Treatment IND Program
  14 Oct 2009
   
Generex Biotechnology to Hold Conference Call On Thursday to Update Investors On Generex Oral-lyn(TM) and Other Corporate Activities
  14 Oct 2009
   
Homeland Security TV Features Generex Executive to Discuss H1N1 Preparedness and Related Biological Security Issues
  5 Oct 2009
   
Generex Presents Abstracts At Scientific Symposium in Europe
  30 Sep 2009
   
Generex MENA Broadens International Reach
  22 Sep 2009
   
Generex to Raise $12,250,000 in Registered Direct Offering
  14 Sep 2009
   
Generex Announces USFDA Approval of Use of Company's Flagship Buccal Insulin Product, Generex Oral-lyn(TM), Under the USFDA'S Treatment Investigational New Drug (IND) Program
  10 Sep 2009
   
Generex to Present At Rodman & Renshaw Annual Global Investment Conference
  8 Sep 2009
   
Generex Establishes European Subsidiary
  2 Sep 2009
   
Generex Biotechnology Corporation's Synthetic Vaccine Platform Represented At International Swine Flu Conference
  27 Aug 2009
   
Generex Biotechnology CEO Anna Gluskin Featured On BNN News to Discuss Potential for H1N1 Vaccine
  24 Aug 2009
   
Generex Announces Sales Agreement With McCarthy and Sons Service
  18 Aug 2009
   
Generex Raises $5.65 Million in a Registered Direct Offering of Common Stock
  6 Aug 2009
   
Generex Announces Publication of Pre-Clinical Studies Demonstrating Utility of Its Vaccine Platform for Addressing Pandemic Influenza
  5 Aug 2009
   
Showing 1-40 of 351 Page: 1 2 3 ... 9  Next 40